Most pigment-grade titanium dioxide (TiO 2 ) samples that have been tested in pulmonary toxicity tests have been of a generic variety-i.e., generally either uncoated particles or TiO 2 particles containing slightly hydrophilic surface treatments/coatings (i.e., base TiO 2 ). The objectives of these studies were to assess in rats, the pulmonary toxicity of inhaled or intratracheally instilled TiO 2 particle formulations with various surface treatments, ranging from 0-6% alumina (Al 2 O 3 ) or alumina and 0-11% amorphous silica (SiO 2 ). The pulmonary effects induced by TiO 2 particles with different surface treatments were compared to reference base TiO 2 particles and controls. In the first study, groups of rats were exposed to high exposure (dose) concentrations of TiO 2 particle formulations for 4 weeks at aerosol concentrations ranging from 1130-1300 mg/m 3 and lung tissues were evaluated by histopathology immediately after exposure, as well as at 2 weeks and 3, 6, and 12 months postexposure. In the second study, groups of rats were intratracheally instilled with nearly identical TiO 2 particle formulations (when compared to the inhalation study) at doses of 2 and 10 mg/kg. Subsequently, the lungs of saline-instilled and TiO 2 -exposed rats were assessed using both bronchoalveolar (BAL) biomarkers and by histopathology/cell proliferation assessment of lung tissues at 24 h, 1 week, 1 and 3 months postexposure.
Many of the commercially available, pigment-grade titanium dioxide products contain surface treatments/coatings with diverse compositions of alumina or alumina and amorphous silica adhered to the TiO 2 particle surface (Figs. 1a and 1b) . The surface treatments are utilized for a variety of applications, including facilitating dispersion, enhanced protection from ultraviolet radiation, wearing, plastics, etc. However, with regard to the toxicity of TiO 2 and most other particle-types, it is noteworthy that virtually all of the inhalation/pulmonary hazard studies have been conducted with ''standard reference'' particle-types, containing few if any surface treatments. This represents a bit of a dilemma-because most of the particletypes to which people are exposed in the occupational and ambient environments are likely to contain particle-types with some form of surface treatments. The toxicity database for fine particle size (~0.3 lm), pigment-grade, base (hydrophilic) titanium dioxide particles is well documented as a low toxicity particulate (Bermudez et al., 2002; Hext, 1994; Muhle et al., 1991; Vu, 1996; Warheit et al., 1997) . The adverse pulmonary effects reported in rats occur only at high-dose, overload exposure concentrations in longer-term toxicity studies in rats at 250 mg/m 3 (Bermudez et al., 2002; Lee et al., 1986; Warheit et al., 1997) . Most of these adverse effects have not been observed in similarly exposed mice or hamsters (Bermudez et al., 2002) and generally it is recognized that, with regard to the pulmonary effects of particle exposures, rats are the most sensitive rodent species (Hext, 1994) .
The aims of this study were (1) to conduct a high-dose 4-week inhalation study in rats using several TiO 2 formulation samples; (2) to assess in rats, using a well-developed short-term pulmonary bioassay, the acute pulmonary toxicity of several intratracheally instilled TiO 2 particle-type samples using similar or identical TiO 2 formulations (as in the inhalation study); and (3) to bridge the results of the intratracheal instillation particle study with data generated from the inhalation study, using the base TiO 2 particle-types as the inhalation/instillation bridge.
Pulmonary bridging studies can serve to provide relevant and accurate screening hazard data when assessing the safety of compounds in commercial development or when making modifications to existing products, such as surface treatments on particulates. The strength of the bridging strategy is dependent upon having good inhalation toxicity data for comparisons to data developed from instillation studies. The materials for which there is inhalation data can then be used as reference particle-types for comparison to the pulmonary bioassay (i.e., instillation) results (see Fig. 2 ). Thus, in describing the basic bridging concept, the effects of the instilled materials serve as a reference (known) particle-type and then are ''bridged'' to the inhalation toxicity data for that particle-type, concomitant with the new materials being tested (compared). The results of bridging studies in rats are then useful as preliminary pulmonary toxicity screening (i.e., hazard) data, because consistency in the response of the inhaled and instilled control material serves to validate the responses with the newly tested particle-type.
MATERIALS AND METHODS
General objectives. The general objectives of this study were the following:
To conduct a 4-week, high dose inhalation study in rats with several TiO 2 formulations and compare the effects with reference (base) TiO 2 samples.
To assess the acute pulmonary toxicity of several formulations of intratracheally instilled TiO 2 formulations and compare the effects with reference TiO 2 .
To bridge the results of the instillation study with data generated from inhalation study.
Animals. Groups of male Crl:CD(SD)IGS BR rats (Charles River Laboratories, Inc., Wilmington, MA [inhalation] and Raleigh, NC [instillation]) were utilized in both the inhalation and instillation studies (CDIGS is the Charles River designation for SD, Sprague Dawley rats). The rats were approximately 8 weeks old at study start (body weights in the range of 240-255 g). All procedures using animals were reviewed and approved by the Institutional Animal Care and Use Committee and the animal program is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC).
Particle types. Several rutile-type titanium dioxide formulations were tested in the two studies. The compositions of the nearly identical TiO 2 formulations for both inhalation and intratracheal instillation studies are presented in Table 1 . Particle sizes and corresponding surface areas (as measured by the BET nitrogen method; Brunauer et al., 1938) of the various TiO 2 formulations are presented in Table 2 . It should be noted that Base TiO 2 and TiO 2 -I formulations are used commercially as a white pigment in plastics. TiO 2 formulation II is used as a white pigment for interior paints. TiO 2 formulations III and IV are utilized in exterior paints; and TiO 2 formulation V is utilized in a wide variety of painting applications, including automotive paints. All TiO 2 particle formulations (rutile type) were obtained from the DuPont Company (Wilmington, DE).
General Experimental Design
Inhalation study (see Fig. 3 for protocol). Six separate four-week inhalation studies were conducted with 6 different TiO 2 formulations (see
Schematic of a TiO 2 particle with surface treatments containing amorphous silica and alumina (as the outer coating) (e.g., TiO 2 formulations III, IV, and V). Some of the TiO 2 particle-types contain either co-oxidized Al 2 O 3 (which is an integral component of the TiO 2 particle and not specifically deposited on the surface-Base TiO 2 and TiO 2 formulation I); other TiO 2 particle formulations contain only alumina on the outer coating surface (e.g., TiO 2 formulation II). (b) Scanning electron micrograph of TiO 2 particles containing surface treatments of alumina and amorphous silica. The median diameter of the particle-types is approximately 300 nm. Schematic of bridging study concept. The basic idea for the bridging concept is that the effects of the instilled material serve as a reference (known) material (Base TiO 2 particles) and then are ''bridged'' on the one hand to the inhalation toxicity data for that particle-type, and on the other hand to the new materials being tested. In this case the results of instillation studies with the formulations are also compared to the results from inhalation studies.
Pulmonary Bioassay Bridging
PULMONARY TOXICITY OF TiO 2 PARTICLES 515 Tables 1 and 2 ). For each study, 25 male rats, approximately 50 days of age, were exposed to test atmospheres 6 h/day, 5 days/week over a 4-5 week period for a total of 20 exposures. Four groups of 25 age-matched male rats were similarly exposed to room air only and served as controls. Rats exposed to TiO 2 formulation particle-types I and II, and rats exposed to TiO 2 formulation dusts III and IV shared common control groups.
Rats were exposed to TiO 2 aerosols in 1.4 m 3 Rochester exposure chambers constructed of stainless steel. The chambers were operated in a one-pass flow model. Atmospheres of TiO 2 dust were generated by withdrawing the TiO 2 from a reservoir utilizing a metal auger attached to a variable speed motor. The dust flowed into a venture tube tangentially attached to the bottom of an inverted U-shaped Plexiglass tube, 3 feet long by 6 inches in diameter, which served as an elutriator. The elutriator was positioned on top of the chamber. Dust particles were dispersed and carried through the generation system with compressed house air. Airflow through the chamber was controlled by a gate valve located in the chamber exhaust line.
Chamber atmospheric concentrations of TiO 2 were determined using gravimetric methods. Particle sizes in the form of aerodynamic mass median diameter of the dust particles were determined using a cascade impactor.
Immediately following the last exposure, as well as 14 days, 3, 6, and 12 months postexposure, 5 rats from each of the control and test groups were sacrificed by chloroform anesthesia and exsanguinations and subjected to a histopathological evaluation. Body and lung weights were determined from all rats necropsied.
Pulmonary bioassay instillation study (see Fig. 4 ). The primary features of this pulmonary bioassay are (1) dose response assessments, and (2) time course evaluations to gauge the persistence of any observed effect. Thus, the major endpoints of this study were the following: (1) time course and dose/ response intensity of pulmonary inflammation and cytotoxicity; and (2) cell proliferation and histopathological assessments of particle-exposed lung tissues.
Groups of male rats were exposed via intratracheal instillation to saline or the TiO 2 particle formulations listed in Table 1 at doses of 2 or 10 mg/kg. All particle-types were suspended in saline. The exposure period was followed by 24-h, 1-week, 1-month, and 3-month recovery periods. At the end of each recovery period, rats from each group were sacrificed for bronchoalveolar lavage (BAL) studies (4/group/time point) or for lower respiratory tract histopathology (4/group/time point).
Bronchoalveolar lavage. The lungs of sham and TiO 2 -exposed rats were washed via bronchoalveolar lavage (BAL) with a phosphate-buffered saline (PBS) solution. Procedures for cell counts, differentials and pulmonary biomarkers in BAL fluids were implemented as previously reported (Warheit et al., 1991) . The first 12 ml of BAL fluids recovered from the lungs of salineor-TiO 2 -exposed rats were centrifuged at 700 3 g, and 2 ml of the supernatant 
Organic, refers to triethanolamine. Base TiO 2 , and TiO 2 -I, -II, -IV, and -V formulations are identical between the two studies. TiO 2 -III formulations differ slightly between the two studies. Note. AMO ¼ amorphous silica. Organic, refers to triethanolamine. Co-oxidized refers to a process wherein alumina is an integral component of the particle and not specifically distributed on the particle surface. Morphological studies. The lungs of rats exposed to TiO 2 particles or saline were prepared for microscopy by airway infusion of a 10% formalin solution under pressure (21 cm H 2 O) at 24 h, 1 week, 1 and 3 months postexposure. Sagittal sections of the left and right lungs were made with a razor blade. Tissue blocks were dissected from left, right upper, and right lower regions of the lung and were subsequently prepared for light microscopy (paraffin embedded, sectioned, and hematoxylin-eosin stained), as described previously (Warheit et al., 1991 (Warheit et al., , 1997 .
Exposure Groups
Statistical analyses. For analysis, each of the experimental values were compared to their corresponding sham control values for each time point. A one-way ANOVA and Bartlett's test were calculated for each sampling time. When the F test from ANOVA was significant, the Dunnett test was used to compare means from the control group and each of the groups exposed to titanium dioxide. Significance was judged at the 0.05 probability level.
RESULTS

Inhalation Study
Mean concentration and particle size of TiO 2 dusts. The mean daily concentration and particle sizes of TiO 2 for the six inhalation studies are shown in Table 3 . The actual concentrations attained were not substantially different from the desired nominal concentrations of 1000 mg/m 3 . Furthermore, the particle sizes of the TiO 2 dusts were similar for all formulations and the respirable fraction for each formulation was considered to be approximately 100%.
Mean body weights and body weight gains. During the 4-week exposure period, lower mean body weights of rats exposed to all of the TiO 2 formulations were measured when compared to controls. Although most groups recovered during the postexposure periods, mean body weights for groups exposed to TiO 2 formulations I and III were still depressed during the 12-month recovery period (Table 4) , although these results were not statistically different from controls.
Mean absolute lung weights of rats exposed to the different TiO 2 formulations were significantly elevated when compared to corresponding controls.
The greater lung weights were evident at the end of the 4-week exposure period as well as throughout the 12-month recovery period (see Table 4 ).
Histopathology. By the end of the 4-week exposure period, the inhaled dust particles for all TiO 2 formulations were heavily concentrated within the bronchioles, alveolar ducts, and alveoli where the dust particles had been mostly phagocytized by the alveolar macrophages. In addition, dust cell (particle-containing macrophages) accumulation and alveolar cell hyperplasia were observed in all TiO 2 -exposed rats at both the 14-day and 3-month postexposure evaluations. For all TiO 2 formulations, there was a marked reduction in dust cells and alveolar cell proliferation but particle-containing macrophages were still evident at the 6 and 12-month postexposure time periods.
At the 3-month postexposure evaluation period, rats that had been exposed to TiO 2 formulations III and V exhibited hyperplasia of the alveolar Type II epithelial cells and disintegration of dust cells which released numerous dust particles into the alveoli. Alveolar cell hyperplasia, observed at the 3-month postexposure time point, was also evident at the 6 and 12-month postexposure evaluations in rats exposed to TiO 2 formulations III and V. In addition to slight collagen deposition, which represents a fibrogenic response in the dust-accumulated areas of the alveoli of rats exposed to TiO 2 formulation III, some alveoli were filled with an eosinophilic proteinaceous material.
At the 1-year postexposure evaluation period, macrophages containing particle aggregates were observed mainly in the alveolar ducts adjacent to alveoli. However, no significant adverse lung tissue reactions to particle deposition were observed in rats exposed to base TiO 2 particles (Figs. 5a and 5b), or to TiO 2 formulations I, II, and IV. Most adverse lung tissue reactions observed in rats exposed to TiO 2 formulation V were resolved by 1-year postexposure. Histopathological observations of the lungs of rats exposed for 4 weeks to TiO 2 formulation III revealed diffuse, particle-containing macrophage accumulation in the alveolar duct regions (Figs. 6a and 6b) which was often associated with alveolar epithelial cell hyperplasia ( Figure 6b ) and occasional collagen deposition in the alveolar duct regions (Figure 6b ). In particular, the micrograph in Figure 6b demonstrates the thickened alveolar walls enclosing particle-containing macrophages, in association with hyperplasia of alveolar epithelial cells and proliferation of fibroblasts.
In summary, the pulmonary responses to the following TiO 2 formulations-Base, I, II, IV, and V generally were characterized by TiO 2 particle-containing macrophage accumulation reactions and light alveolar cell hyperplasia at the end of the 4-week exposure period. Small degrees of alveolar cell hyperplasia and macrophage accumulation were still evident at the 12-month postexposure time period. In addition, slight collagen deposition was observed only in rats exposed to TiO 2 formulation III, the formulation containing the largest composition of alumina and amorphous silica surface treatments, and having the largest surface area values.
Pulmonary Bioassay Study (Intratracheal Instillation Exposures)
Pulmonary inflammation. The numbers of cells recovered by bronchoalveolar lavage from the lungs of any of the TiO 2 -exposed groups were not significantly different from salineinstilled controls at any postexposure time point (data not shown). Intratracheal instillation exposures at 2 mg/kg dose for TiO 2 -III and V formulations; and at 10 mg/kg for all of the TiO 2 formulations tested produced a short-term pulmonary inflammatory response, as evidenced by an increase in the numbers and percentages of BAL neutrophils at 24 h postexposure. At 1 week and subsequent evaluations, there were no significant differences between saline control animals and TiO 2 treated animals, indicating a transient inflammatory effect (Fig. 7) . However, exposures to 10 mg/kg TiO 2 -III or TiO 2 V formulations produced a more sustained lung inflammatory response, with the responses to TiO 2 -V and TiO 2 -III returning to control levels at 1 month (TiO 2 -V) or 3 months (TiO 2 -III) postexposure, respectively (Fig. 7) . BAL fluid parameters. Transient significant increases compared to saline controls in BAL fluid lactate dehydrogenase values were measured in the lungs of (10 mg/kg) TiO 2 -I and TiO 2 -II exposed rats only at 24 h postexposure, but were not sustained throughout the other postexposure time periods (Fig. 8) . In contrast, exposures to TiO 2 -V formulation produced significant increases in BAL LDH values at 1 week postexposure, and exposures to TiO 2 -III particle formulations produced sustained increases in cytotoxicity endpoints through 1 month postexposure.
Transient significant increases compared with saline controls in BAL fluid microprotein values were measured in the lungs of (10 mg/kg) TiO 2 -II and TiO 2 -IV exposed rats at 24 h postexposure, but were not sustained throughout the other postexposure time periods (Fig. 9) . In contrast, exposures to TiO 2 -V formulation produced significant increases in BAL microprotein values at 1 week postexposure, and exposures to TiO 2 -III particle-types produced sustained increases in lung permeability endpoints through 1 week postexposure.
No significant increases were measured in BAL fluid alkaline phosphatase values among any of the particle-exposed groups when compared to saline controls (data not shown).
Similarly, no significant increases compared with salineinstilled controls were measured in BrdU lung cell proliferation rates in lung parenchymal cells (Fig. 10) or tracheobronchial epithelial cells (data not shown) of groups exposed to TiO 2 coatings formulations at 24 h, 1 week, 1 month, and 3 months postexposure.
Lung morphology. Histopathological analyses of lung tissues revealed no significant morphological differences among the exposed TiO 2 formulation groups. Most of the lung tissue sections demonstrated particle-laden macrophages at bronchoalveolar junctions following instillation of particles (Fig. 11) . Assessments of lung tissue sections following exposures to all of the TiO 2 particle formulations demonstrated a normal architecture at all time periods postexposure.
DISCUSSION
Inhalation Studies
Six groups of 25 male rats were exposed by inhalation 6 h/d, 5 days/week for a total of 20 exposures to one of six TiO 2 formulations. These 4-week inhalation toxicity studies were conducted at very high aerosol concentrations in order to provide a hazard screen to determine whether surface treatments drastically modified the toxicity of inhaled TiO 2 particles. Compared to their respective controls, the mean body weights of rats exposed to all of the TiO 2 formulations were reduced during the 4-week exposure period although the mean body weights of the rats in most TiO 2 formulation exposure groups with the exception of TiO 2 groups I and III were comparable to controls in the 12-month recovery group. When compared to air controls, significantly higher mean absolute lung weights were measured at the end of the 4-week exposure period and, with one exception, throughout the 12-month postexposure recovery period for all TiO 2 treatment groups throughout the study.
Histological evaluation of the particle-exposed lungs revealed that, overall, the pulmonary responses, as evidenced by dust clearance and Alveolar Type II epithelial cell hyperplasia, were similar for the different TiO 2 formulations. However, the degree of dust clearance and proliferation response of the alveolar Type II epithelial cells were slightly different for the different TiO 2 formulations. Additionally, slight collagen deposition was observed in rats exposed to TiO 2 formulation III but no significant collagen deposition was observed in rats exposed to the other TiO 2 formulations.
The TiO 2 -related histopathological effects observed in the inhalation study clearly were due to particle overload. In this regard, we have previously reported that aerosols exposures to base TiO 2 particles in rats for 4 weeks at concentrations of 250 mg/m 3 produced lung burdens of 11 mg TiO 2 /lung, with clearance half-times of 330 days, concomitant with sustained pulmonary inflammation, enhanced proliferation of pulmonary cells, impairment of particle clearance, macrophage functional deficits, and macrophage accumulation at sites of particle deposition (Warheit et al., 1997 ). In the current study, which was designed as a preliminary hazard screen, the aerosol exposure concentrations were approximately 5-fold greater than the aforementioned study. Thus, if exposure concentrations of 250 mg/m 3 produced~11 mg/lung dust burden and particle overload pulmonary effects, then exposures of 1300 mg/m 3 would likely produce estimated lung burdens of~40-50 mg TiO 2 /lung, along with corresponding particle overload effects. In this regard, it is remarkable that high dose exposures did not produce lung fibrosis in any of the TiO 2 formulations other than TiO 2 formulation III.
Exposures of rats to TiO 2 formulations with higher contents of Al 2 O 3 and/or amorphous SiO 2 (TiO 2 formulations III and IV) resulted in loose aggregation of dust cells and proliferation of the cells lining the alveoli. Whether the presence of Al 2 O 3 in the TiO 2 formulations was causally related to these histological changes is unclear since Al 2 O 3 was present in each of the TiO 2 formulations and there were no Al 2 O 3 concentration-dependent changes in histology. Additionally, the prolonged pulmonary effects in rats exposed to TiO 2 formulations III and, to a lesser degree, TiO 2 -V are suggestive of a response induced by the presence of amorphous SiO 2 in the formulations. However, in FIG. 7 . Percent neutrophils recovered from BAL fluids of saline and TiO 2 -instilled rats (2 and 10 mg/kg dose). Values given are means ± SD for 4 rats/group/ time period. Intratracheal instillation exposures to the 10 mg/kg base TiO 2 particles produced a short-term pulmonary inflammatory response, as evidenced by an increase in the percentages (and numbers-see Fig. 10 ) of BAL neutrophils, measured at 24 h, but was not significantly different from saline controls at 1 week postexposure, indicating a transient effect. *p < 0.05. the absence of a similar response to TiO 2 formulation IV which also contained amorphous SiO 2 , these data are not conclusive.
In the second study, groups of rats were intratracheally instilled with nearly identical TiO 2 particle formulations to the inhalation study, at doses of 2 and 10 mg/kg. Following exposures, the lungs of saline-instilled and TiO 2 formulationexposed rats were evaluated using bronchoalveolar (BAL) biomarkers as well as histopathology/cell proliferation evaluation of lung tissues at 24 h, 1 week, 1 and 3 months postexposure. The results from the two studies were compared with their respective reference control materials and were also bridged (i.e., comparing inhalation results with instillation results). Remarkably, the results were quite similar for the two studies and demonstrated that only the TiO 2 particle formulations, TiO 2 -V and TiO 2 -III which contained the largest concentrations of alumina and amorphous silica on their surfaces [85% TiO 2 -7% Al þ 8% AMO-inhalation study; 82% TiO 2 -7% Al þ 11% AMO-instillation study] produced mildly adverse pulmonary effects compared to base TiO 2 control particle-types. It is also interesting to note that TiO 2 formulation III does not have the smallest particle size (440 nm) but has the greatest surface area (27.8 m 2 /g) among all of the TiO 2 formulations.
Bridging studies can have value in hazard evaluations when making a small modification to an existing chemical product, or when screening the safety of new developmental compounds. The reliability of accurate lung toxicity bridging studies is dependent upon having good inhalation toxicity data on the reference particulates. The reference particle-type for which there is inhalation toxicity data in rats then can be used as a control material for an intratracheal instillation bridging study. Accordingly, the basic bridging concept is that the effects of the instilled material serve as a reference material and then are ''bridged'' to the inhalation toxicity data for that material, and to the new test materials being evaluated. It should be noted however, that these pulmonary bioassay studies are effective screening tools, but do not substitute for more substantial inhalation toxicity studies, such as 4-week inhalation, 90-day inhalation studies, or 2-year inhalation bioassay studies.
Recently, utilizing a bridging study technique (i.e., comparing the effects of coated TiO 2 particulates with base TiO 2 particles), we reported the results of pulmonary toxicity studies in rats with commercial, hydrophobic-coated, pigment-grade TiO 2 particles. In that study, we concluded that the OTES (triethoxyoctylsilane-hydrophobic) surface treatment on the pigment-grade TiO 2 particle did not cause significant pulmonary toxicity and the pulmonary effects measured were not significantly different from the effects produced by exposure to hydrophilic TiO 2 base (reference) particle samples (Warheit et al., 2003) . Several investigators have considered the toxicological effects of coatings on TiO 2 particles. Hohr and collaborators (2002) investigated the acute lung inflammatory responses following intratracheal instillation exposures of surface modified (hydrophilic and hydrophobic), fine (180 nm), or ultrafine (20-30 nm) TiO 2 particles in rats at equivalent mass doses (1 or 6 mg) or surface area doses (100, 500, 600, and 3000 cm 2 ). These investigators concluded that BAL fluid biomarkers of inflammation were correlated with the administered surface dose delivered to the lungs. Exposures to hydrophobic-coated TiO 2 particles produced less pulmonary inflammation, but these effects were not significantly different from those produced by hydrophilic-coated particulates. The investigators concluded that the surface area rather than the hydrophobic surface coating determines the acute lung inflammatory response induced by instillation of either fine or ultrafine TiO 2 particle-types. Rehn and coworkers (2003) assessed the pulmonary inflammatory and genotoxic effects of two types of ultrafine titanium dioxide particles in the lungs of female rats. Rats were exposed by intratracheal instillation to varying concentrations of uncoated (P-25) or hydrophobic-coated (T-805), ultrafine TiO 2 particles and the effects were assessed at 3, 21, and 90 days postexposure. Crystalline silica, quartz particles (DQ12) and saline were utilized as positive reference and negative controls, respectively. Quartz exposure produced a persistent pulmonary inflammatory response, measured through 90 days postexposure. In contrast, rats exposed to both types of TiO 2 produced no inflammation 90 days after exposure. These investigators concluded that neither the uncoated or hydrophobically coated TiO 2 produced any significant pulmonary effects.
Oberdorster (2001) exposed rats via intratracheal instillation to two different types of aggregated ultrafine TiO 2 particletypes (particle size of both types~20 nm) at doses of 50 and 500 lg/rat. One type was hydrophilic, while the other type was silane-coated, making the particle surface hydrophobic. Exposures to hydrophobic-coated, ultrafine TiO 2 particles induced a much lower pulmonary inflammatory response at 24 h postexposure when compared to identical doses of the hydrophilic TiO 2 particle-types. The author indicated that these results appear to contrast with an earlier report by Pott et al. (1998a,b) , who reported that larger doses of instilled hydrophobic-coated, but not uncoated ultrafine TiO 2 particles were acutely toxic and lethal.
With regard to the bridging study conducted herein, there is substantial evidence to suggest that inhalation of base pigmentgrade TiO 2 particles produces low pulmonary toxicity in exposed rats (Bermudez et al., 2002; Hext, 1994; Muhle et al., 1991; Vu, 1996; Warheit et al., 1997) . In the current study, a large dose of intratracheally instilled base TiO 2 particles (10 mg/kg) produced only a short-term, transient lung inflammatory response, measured at 24 h postexposure. These effects were reversible at one week postexposure. Thus, the inhalation data and the instillation toxicity results for base TiO 2 particles in rats are consistent-i.e., clearly demonstrating that pulmonary exposures produce few adverse effects. This is in contrast to the pulmonary effects measured following inhalation (Warheit et al., 1991) or instillation exposures (Zhang et al., 2002) to crystalline silica particles, which produced sustained pulmonary inflammation leading to the development of fibrosis, in both inhalation and instillation models.
Surface treatments form an important commercial component of titanium dioxide formulations and are utilized in numerous applications (e.g., paper, plastics, etc.). Most of the hydrophilic surface treatments on pigment-grade titanium dioxide particles contain varying concentrations of aluminum oxide or aluminum oxide and amorphous silica-ranging from 1-11%. However, virtually all of the pigment-grade TiO 2 samples that been tested in inhalation toxicity studies have been only slightly hydrophilic-coated TiO 2 samples containing 1% aluminum oxide. Questions have been raised regarding the potential lung toxicity associated with commercial surface treatments on pigment-grade particles. The results of studies produced herein demonstrate that the bridging concept provides an effective screening tool for assessing the lung toxicity of TiO 2 particle formulations containing various surface treatments.
In summary, a pulmonary bridging strategy has been presented to assess the toxicity of similar-sized particulates with small surface modifications. In this case, pulmonary toxicity comparisons were made of inhaled and instilled TiO 2 formulations, and the results generated from the instilled base TiO 2 particles were consistent with findings from an inhalation toxicity using TiO 2 formulations with virtually identical surface treatments. Thus, three major conclusions can be drawn from these studies: (1) lung exposure in rats (the most sensitive species; Hext, 1994) to even exceedingly high concentrations of titanium dioxide particles produces low pulmonary toxicity; (2) surface treatments can influence the toxicity of TiO 2 particles in the lung; TiO 2 formulation III produced adverse lung effects compared to base TiO 2 and other formulations, but even these impacts would be viewed as minor when compared to other dusts; and (3) the intratracheal instillation-derived, pulmonary bioassay methods represent an effective preliminary screening tool for gauging the safety of inhaled TiO 2 formulations utilized in this study.
